Status:
UNKNOWN
Tuberculosis Screening in Paraguayan Prisons
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
European Union
Instituto de Saude Publica da Universidade do Porto
Conditions:
Volatile Organic Compounds
Radiography
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Two diagnostic tools for TB screening in high risk groups need additional assessment: the AeoNose™, an 'electronic nose device' for breath sampling, and digital chest X-ray (CXR) with computer aided d...
Detailed Description
The aim of the World Health Organization (WHO) "End TB Strategy" is to end the global pandemic by 2035. To be able to succeed, better point-of-care (POC) tests are urgently needed to improve screening...
Eligibility Criteria
Inclusion
- All persons, either being a prisoner or employee, of the involved penal institutions after providing informed consent, including those with known active TB disease and/or currently on TB treatment
Exclusion
- A potential participant who meets any of the following criteria will be excluded from participation in this study:
- Unable to exhale breath through the AeoNose™ during five minutes due to respiratory insufficiency
- Unable to stand in an upright position for the CXR
- Unable to communicate and comply with the instructions of the study team
Key Trial Info
Start Date :
October 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04407325
Start Date
October 18 2021
End Date
December 1 2023
Last Update
April 3 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Buen Pastor
Asuncion, Central Department, Paraguay
2
UPI
Asuncion, Central Department, Paraguay